T. Rowe Price Investment Management’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$325M Buy
7,629,151
+1,505,286
+25% +$60.6M 0.22% 110
2025
Q4
$229M Buy
6,123,865
+1,091,757
+22% +$36.6M 0.14% 156
2025
Q3
$149M Buy
5,032,108
+138,708
+3% +$3.22M 0.09% 217
2025
Q2
$115M Sell
4,893,400
-879,372
-15% -$18.3M 0.07% 256
2025
Q1
$104M Buy
5,772,772
+4,189,805
+265% +$82.3M 0.07% 269
2024
Q4
$27M Buy
+1,582,967
New +$27.4M 0.02% 491

Other funds holding BTSG

T. Rowe Price Investment Management's BTSG Position: Q1 2026 in Review

T. Rowe Price Investment Management increased its BrightSpring Health Services (BTSG) stake by 25% in Q1 2026, buying an estimated $60.6M and bringing the position to 7,629,151 shares worth $325M. The position accounts for 0.22% of the portfolio, ranked #110.

T. Rowe Price Investment Management first reported a position in BTSG in Q4 2024 and has held it in 6 quarters since. 336 funds tracked by Wall St. Rank hold BTSG as of Q1 2026.

  • T. Rowe Price Investment Management held 7,629,151 shares of BrightSpring Health Services worth $325M as of Q1 2026.
  • T. Rowe Price Investment Management bought 1,505,286 BrightSpring Health Services shares in Q1 2026, an estimated $60.6M.
  • BrightSpring Health Services made up 0.22% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #110 holding.
  • T. Rowe Price Investment Management first reported a position in BrightSpring Health Services in Q4 2024 and has held it in 6 quarters since.
  • 336 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.